{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:38:56Z","timestamp":1790617136747,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T00:00:00Z","timestamp":1423699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12016-015-8469-8","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T08:06:32Z","timestamp":1423641992000},"page":"317-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye"],"prefix":"10.1007","volume":"49","author":[{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dunogu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moez","family":"Jallouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine P.","family":"Br\u00e9zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Melles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Marmor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,12]]},"reference":[{"key":"8469_CR1","unstructured":"Costedoat-Chalumeau N, Leroux G, Piette J-C, Amoura Z (2010) Antimalarials and systemic lupus erythematosus. In: Lahita RG, Tsokos G, Buyon JP, Koike T (eds) Systemic lupus erythematosus, 5th edn. Elsevier, 1061\u20131081"},{"key":"8469_CR2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","volume":"15","author":"G Ruiz-Irastorza","year":"2006","unstructured":"Ruiz-Irastorza G, Egurbide MV, Pijoan JI et al (2006) Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15:577\u2013583","journal-title":"Lupus"},{"key":"8469_CR3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarcon","year":"2007","unstructured":"Alarcon GS, McGwin G Jr, Bertoli AM et al (2007) Effect of hydroxychloroquine in the survival of patients with systemic lupus erythematosus. data from lumina, a multiethnic us cohort (LUMINA L). Ann Rheum Dis 66:1168\u20131172","journal-title":"Ann Rheum Dis"},{"key":"8469_CR4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/art.27300","volume":"62","author":"SK Shinjo","year":"2010","unstructured":"Shinjo SK, Bonfa E, Wojdyla D et al (2010) Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis Rheum 62:855\u2013862","journal-title":"Arthritis Rheum"},{"key":"8469_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000094079","volume":"107","author":"N Costedoat-Chalumeau","year":"2006","unstructured":"Costedoat-Chalumeau N, Hulot JS, Amoura Z et al (2006) Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology 107:73\u201380","journal-title":"Cardiology"},{"key":"8469_CR6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","volume":"132","author":"RB Melles","year":"2014","unstructured":"Melles RB, Marmor MF (2014) The risk of toxic retinopathy in long-term hydroxychloroquine therapy. JAMA Ophthalmol 132:1453\u20131460","journal-title":"JAMA Ophthalmol"},{"key":"8469_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","volume":"118","author":"MF Marmor","year":"2011","unstructured":"Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:415\u2013422","journal-title":"Ophthalmology"},{"key":"8469_CR8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaophthalmol.2014.1099","volume":"132","author":"MF Marmor","year":"2014","unstructured":"Marmor MF, Hu J (2014) Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol 132:1105\u20131112","journal-title":"JAMA Ophthalmol"},{"key":"8469_CR9","first-page":"294","volume":"12","author":"JC Yam","year":"2006","unstructured":"Yam JC, Kwok AK (2006) Ocular toxicity of hydroxychloroquine. Hong Kong Med J 12:294\u2013304","journal-title":"Hong Kong Med J"},{"key":"8469_CR10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.56.3.188","volume":"56","author":"DJ Grierson","year":"1997","unstructured":"Grierson DJ (1997) Hydroxychloroquine and visual screening in a rheumatology outpatient clinic. Ann Rheum Dis 56:188\u2013190","journal-title":"Ann Rheum Dis"},{"key":"8469_CR11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00417-006-0365-8","volume":"245","author":"A Dosso","year":"2007","unstructured":"Dosso A, Rungger-Brandle E (2007) In vivo confocal microscopy in hydroxychloroquine-induced keratopathy. Graefes Arch Clin Exp Ophthalmol 245:318\u2013320","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"8469_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/08820530802049962","volume":"23","author":"R Tehrani","year":"2008","unstructured":"Tehrani R, Ostrowski RA, Hariman R, Jay WM (2008) Ocular toxicity of hydroxychloroquine. Semin Ophthalmol 23:201\u2013209","journal-title":"Semin Ophthalmol"},{"key":"8469_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archophthalmol.2011.371","volume":"130","author":"MF Marmor","year":"2012","unstructured":"Marmor MF (2012) Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol 130:461\u2013469","journal-title":"Arch Ophthalmol"},{"key":"8469_CR14","doi-asserted-by":"crossref","unstructured":"Melles\u00a0RB,\u00a0Marmor\u00a0MF (2015)\u00a0Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.\u00a0Ophthalmology 122:110-116","DOI":"10.1016\/j.ophtha.2014.07.018"},{"key":"8469_CR15","doi-asserted-by":"crossref","unstructured":"Lee DH, Joe SG, Lee JY, Kim J-G, Lee CG, Yoo B, Koo BS, Melles RB, Marmor, MF, Yoon, YH (2015)\u00a0Pericentral hydroxychloroquine retinopathy in Korean patients. Ophthalmology (in press)","DOI":"10.1016\/j.ophtha.2015.01.014"},{"key":"8469_CR16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Marmor MF (2010) Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62:775\u2013784","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8469_CR17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(83)91269-X","volume":"75","author":"AH Mackenzie","year":"1983","unstructured":"Mackenzie AH (1983) Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 75:40\u201345","journal-title":"Am J Med"},{"key":"8469_CR18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/bjo.2009.174458","volume":"94","author":"R Bergholz","year":"2010","unstructured":"Bergholz R, Schroeter J, Ruther K (2010) Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine. Br J Ophthalmol 94:1637\u20131642","journal-title":"Br J Ophthalmol"},{"key":"8469_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0008-4182(02)80001-1","volume":"37","author":"M Easterbrook","year":"2002","unstructured":"Easterbrook M (2002) Screening for antimalarial toxicity: current concepts. Can J Ophthalmol 37:325\u2013328","journal-title":"Can J Ophthalmol"},{"key":"8469_CR20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamaophthalmol.2013.4244","volume":"131","author":"M Mititelu","year":"2013","unstructured":"Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA (2013) Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. JAMA Ophthalmol 131:1187\u20131197","journal-title":"JAMA Ophthalmol"},{"key":"8469_CR21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","volume":"27","author":"N Costedoat-Chalumeau","year":"2013","unstructured":"Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G et al (2013) Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 27:329\u2013340","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8469_CR22","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2012-202322","volume":"72","author":"N Costedoat-Chalumeau","year":"2013","unstructured":"Costedoat-Chalumeau N, Galicier L, Aumaitre O et al (2013) Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Ann Rheum Dis 72:1786\u20131792","journal-title":"Ann Rheum Dis"},{"key":"8469_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jps.2600810211","volume":"81","author":"SE Tett","year":"1992","unstructured":"Tett SE, Cutler DJ, Day RO (1992) Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques. J Pharm Sci 81:155\u2013159","journal-title":"J Pharm Sci"},{"key":"8469_CR24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0961203313476361","volume":"22","author":"JY Lee","year":"2013","unstructured":"Lee JY, Luc S, Greenblatt DJ, Kalish R, McAlindon TE (2013) Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important. Lupus 22:541\u2013542","journal-title":"Lupus"},{"key":"8469_CR25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9394(01)00838-8","volume":"131","author":"NF Shroyer","year":"2001","unstructured":"Shroyer NF, Lewis RA, Lupski JR (2001) Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 131:761\u2013766","journal-title":"Am J Ophthalmol"},{"key":"8469_CR26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/art.10307","volume":"46","author":"T Munster","year":"2002","unstructured":"Munster T, Gibbs JP, Shen D et al (2002) Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis Rheum 46:1460\u20131469","journal-title":"Arthritis Rheum"},{"key":"8469_CR27","first-page":"1656","volume":"27","author":"SE Tett","year":"2000","unstructured":"Tett SE, Cutler DJ, Beck C, Day RO (2000) Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis\u2014a prospective, dose ranging study. J Rheumatol 27:1656\u20131660","journal-title":"J Rheumatol"},{"key":"8469_CR28","first-page":"1874","volume":"20","author":"SE Tett","year":"1993","unstructured":"Tett SE, Day RO, Cutler DJ (1993) Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis\u2014a cross sectional study. J Rheumatol 20:1874\u20131879","journal-title":"J Rheumatol"},{"key":"8469_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archdermatol.2011.2558","volume":"148","author":"C Frances","year":"2012","unstructured":"Frances C, Cosnes A, Duhaut P et al (2012) Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. Arch Dermatol 148:479\u2013484","journal-title":"Arch Dermatol"},{"key":"8469_CR30","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/art.22156","volume":"54","author":"N Costedoat-Chalumeau","year":"2006","unstructured":"Costedoat-Chalumeau N, Amoura Z, Hulot JS et al (2006) Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 54:3284\u20133290","journal-title":"Arthritis Rheum"},{"key":"8469_CR31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/imj.12100","volume":"43","author":"SJ Carmichael","year":"2013","unstructured":"Carmichael SJ, Day RO, Tett SE (2013) A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus. Intern Med J 43:547\u2013553","journal-title":"Intern Med J"},{"key":"8469_CR32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3899\/jrheum.110771","volume":"39","author":"TV Ting","year":"2012","unstructured":"Ting TV, Kudalkar D, Nelson S et al (2012) Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol 39:174\u2013179","journal-title":"J Rheumatol"},{"key":"8469_CR33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.38243","volume":"66","author":"N Costedoat-Chalumeau","year":"2014","unstructured":"Costedoat-Chalumeau N, Le Guern V, Piette JC (2014) Determining adherence to therapeutic regimens in patients with chronic illness: comment on the article by Waimann et Al. Arthritis Rheum 66:770","journal-title":"Arthritis Rheum"},{"key":"8469_CR34","unstructured":"Alexander S, Chusney G, Chusney VD, Lee J, Cairns T, Lightstone L (2013) The Achilles heel of lupus nephritis treatment\u2014identifying non adherence using hydroxychloroquine blood levels (abstract). J Am Soc Nephrol"},{"key":"8469_CR35","doi-asserted-by":"crossref","first-page":"S770","DOI":"10.1002\/art.37818","volume":"65","author":"M Petri","year":"2013","unstructured":"Petri M, Fand H, Clarke W (2013) Hydroxychloroquine levels identify four distinct subsets of systemic lupus erythematosus patients (abstract). Arthritis Rheum 65:S770","journal-title":"Arthritis Rheum"},{"key":"8469_CR36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","volume":"149","author":"M Jallouli","year":"2013","unstructured":"Jallouli M, Frances C, Piette JC et al (2013) Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. JAMA Dermatol 149:935\u2013940","journal-title":"JAMA Dermatol"},{"key":"8469_CR37","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0002-9394(68)91300-7","volume":"66","author":"RE Carr","year":"1968","unstructured":"Carr RE, Henkind P, Rothfield N, Siegel IM (1968) Ocular toxicity of antimalarial drugs. Long-term follow-up. Am J Ophthalmol 66:738\u2013744","journal-title":"Am J Ophthalmol"},{"key":"8469_CR38","first-page":"237","volume":"27","author":"M Easterbrook","year":"1992","unstructured":"Easterbrook M (1992) Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol 27:237\u2013239","journal-title":"Can J Ophthalmol"},{"key":"8469_CR39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0049-0172(10)80009-5","volume":"23","author":"M Easterbrook","year":"1993","unstructured":"Easterbrook M (1993) The ocular safety of hydroxychloroquine. Semin Arthritis Rheum 23:62\u201367","journal-title":"Semin Arthritis Rheum"},{"key":"8469_CR40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10792-013-9791-x","volume":"34","author":"JC Yam","year":"2014","unstructured":"Yam JC, Kwok AK (2014) Ultraviolet light and ocular diseases. Int Ophthalmol 34:383\u2013400","journal-title":"Int Ophthalmol"},{"key":"8469_CR41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.preteyeres.2012.03.002","volume":"31","author":"A Kijlstra","year":"2012","unstructured":"Kijlstra A, Tian Y, Kelly ER, Berendschot TT (2012) Lutein: more than just a filter for blue light. Prog Retin Eye Res 31:303\u2013315","journal-title":"Prog Retin Eye Res"},{"key":"8469_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/138161212798919101","volume":"18","author":"Y Ozawa","year":"2012","unstructured":"Ozawa Y, Sasaki M, Takahashi N, Kamoshita M, Miyake S, Tsubota K (2012) Neuroprotective effects of lutein in the retina. Curr Pharm Des 18:51\u201356","journal-title":"Curr Pharm Des"},{"key":"8469_CR43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","volume":"132","author":"EY Chew","year":"2014","unstructured":"Chew EY, Clemons TE, Sangiovanni JP et al (2014) Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol 132:142\u2013149","journal-title":"JAMA Ophthalmol"},{"key":"8469_CR44","doi-asserted-by":"crossref","unstructured":"Marmor MF, Hu J (2014) Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol 132(9):1105\u20131112","DOI":"10.1001\/jamaophthalmol.2014.1099"},{"key":"8469_CR45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ophtha.2013.12.002","volume":"121","author":"MF Marmor","year":"2014","unstructured":"Marmor MF, Melles RB (2014) Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology 121:1257\u20131262","journal-title":"Ophthalmology"},{"key":"8469_CR46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00417-011-1753-2","volume":"250","author":"S Missner","year":"2012","unstructured":"Missner S, Kellner U (2012) Comparison of different screening methods for chloroquine\/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 250:319\u2013325","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"8469_CR47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0181-5512(04)96119-0","volume":"27","author":"F Rigaudiere","year":"2004","unstructured":"Rigaudiere F, Ingster-Moati I, Hache JC et al (2004) Up-dated ophthalmological screening and follow-up management for long-term antimalarial treatment. J Fr Ophtalmol 27:191\u2013199","journal-title":"J Fr Ophtalmol"},{"key":"8469_CR48","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1167\/iovs.05-1290","volume":"47","author":"U Kellner","year":"2006","unstructured":"Kellner U, Renner AB, Tillack H (2006) Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine\/hydroxychloroquine. Invest Ophthalmol Vis Sci 47:3531\u20133538","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8469_CR49","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajo.2006.12.042","volume":"143","author":"JS Lyons","year":"2007","unstructured":"Lyons JS, Severns ML (2007) Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol 143:801\u2013809","journal-title":"Am J Ophthalmol"},{"key":"8469_CR50","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/eye.2011.245","volume":"25","author":"C Anderson","year":"2011","unstructured":"Anderson C, Blaha GR, Marx JL (2011) Humphrey visual field findings in hydroxychloroquine toxicity. Eye (Lond) 25:1535\u20131545","journal-title":"Eye (Lond)"},{"key":"8469_CR51","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/bjo.2008.144402","volume":"92","author":"AE Semmer","year":"2008","unstructured":"Semmer AE, Lee MS, Harrison AR, Olsen TW (2008) Hydroxychloroquine retinopathy screening. Br J Ophthalmol 92:1653\u20131655","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"8469_CR52","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jamaophthalmol.2014.1720","volume":"132","author":"M Nika","year":"2014","unstructured":"Nika M, Blachley TS, Edwards P, Lee PP, Stein JD (2014) Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users. JAMA Ophthalmol 132(10):1199\u20131208","journal-title":"JAMA Ophthalmol"},{"key":"8469_CR53","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.10150","volume":"46","author":"N Costedoat-Chalumeau","year":"2002","unstructured":"Costedoat-Chalumeau N, Amoura Z, Aymard G et al (2002) Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 46:1123\u20131124","journal-title":"Arthritis Rheum"},{"key":"8469_CR54","first-page":"1715","volume":"23","author":"A Parke","year":"1996","unstructured":"Parke A, West B (1996) Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 23:1715\u20131718","journal-title":"J Rheumatol"},{"key":"8469_CR55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.55.7.486","volume":"55","author":"NM Buchanan","year":"1996","unstructured":"Buchanan NM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GR (1996) Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 55:486\u2013488","journal-title":"Ann Rheum Dis"},{"key":"8469_CR56","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(02)07643-2","volume":"359","author":"M Motta","year":"2002","unstructured":"Motta M, Tincani A, Faden D, Zinzini E, Chirico G (2002) Antimalarial agents in pregnancy. Lancet 359:524\u2013525","journal-title":"Lancet"},{"key":"8469_CR57","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","volume":"358","author":"G Klinger","year":"2001","unstructured":"Klinger G, Morad Y, Westall CA et al (2001) Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 358:813\u2013814","journal-title":"Lancet"},{"key":"8469_CR58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","volume":"10","author":"RA Levy","year":"2001","unstructured":"Levy RA, Vilela VS, Cataldo MJ et al (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10:401\u2013404","journal-title":"Lupus"},{"key":"8469_CR59","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","volume":"54","author":"ME Clowse","year":"2006","unstructured":"Clowse ME, Magder L, Witter F, Petri M (2006) Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54:3640\u20133647","journal-title":"Arthritis Rheum"},{"key":"8469_CR60","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","volume":"48","author":"N Costedoat-Chalumeau","year":"2003","unstructured":"Costedoat-Chalumeau N, Amoura Z, Duhaut P et al (2003) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48:3207\u20133211","journal-title":"Arthritis Rheum"},{"key":"8469_CR61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1546-0096-7-9","volume":"7","author":"K Sperber","year":"2009","unstructured":"Sperber K, Hom C, Chao CP, Shapiro D, Ash J (2009) Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J 7:9","journal-title":"Pediatr Rheumatol Online J"},{"key":"8469_CR62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","volume":"39C","author":"O Diav-Citrin","year":"2013","unstructured":"Diav-Citrin O, Blyakhman S, Shechtman S, Ornoy A (2013) Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. Reprod Toxicol 39C:58\u201362","journal-title":"Reprod Toxicol"},{"key":"8469_CR63","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/art.20648","volume":"50","author":"R Cimaz","year":"2004","unstructured":"Cimaz R, Brucato A, Meregalli E, Muscara M, Sergi P (2004) Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al. Arthritis Rheum 50:3056\u20133057, author reply 3057\u20133058","journal-title":"Arthritis Rheum"},{"key":"8469_CR64","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/art.20649","volume":"50","author":"N Costedoat-Chalumeau","year":"2004","unstructured":"Costedoat-Chalumeau N, Amoura Z, Sebbough D, Piette JC (2004) Reply. Arthritis Rheum 50:3057","journal-title":"Arthritis Rheum"},{"key":"8469_CR65","first-page":"14","volume":"14","author":"M Motta","year":"2004","unstructured":"Motta M, Tincani A, Faden D et al (2004) Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 14:14","journal-title":"J Perinatol"},{"key":"8469_CR66","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1651-2227.2009.01379.x","volume":"98","author":"F Renault","year":"2009","unstructured":"Renault F, Flores-Guevara R, Renaud C, Richard P, Vermersch AI, Gold F (2009) Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero. Acta Paediatr 98:1500\u20131503","journal-title":"Acta Paediatr"},{"key":"8469_CR67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1651-2227.2009.01523.x","volume":"99","author":"I Ingster-Moati","year":"2010","unstructured":"Ingster-Moati I, Albuisson E (2010) Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero. Acta Paediatr 99:4, author reply 4\u20135","journal-title":"Acta Paediatr"},{"key":"8469_CR68","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","volume":"38","author":"A Osadchy","year":"2011","unstructured":"Osadchy A, Ratnapalan T, Koren G (2011) Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature. J Rheumatol 38:2504\u20132508","journal-title":"J Rheumatol"},{"key":"8469_CR69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","volume":"8","author":"M Ostensen","year":"2006","unstructured":"Ostensen M, Khamashta M, Lockshin M et al (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8:209","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8469-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8469-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8469-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T20:58:48Z","timestamp":1566334728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8469-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,12]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8469"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8469-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,12]]}}}